PURLs: would this long-acting bronchodilator be better for your patient?
Tiotropium outperformed salmeterol in reducing the frequency of exacerbations in patients with moderate-to-severe COPD.
Department of Family Medicine, University of North Carolina at Chapel Hill, NC, USA.
Mark
M
Gwynne
Anne
A
Mounsey
D058666:Adrenergic beta-2 Receptor Agonists / Q000627:therapeutic use*; D000368:Aged; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005194:Family Practice / Q000379:methods; D006801:Humans; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000188:drug therapy*; D012602:Scopolamine Derivatives / Q000627:therapeutic use*; D000069447:Tiotropium Bromide; D014481:United States
D058666:Adrenergic beta-2 Receptor Agonists; D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives; D000069447:Tiotropium Bromide